Skip to main content
Clinical Trials/NCT04266691
NCT04266691
Completed
Not Applicable

Molecular Metastasis in Lymph Nodes is Associated With Survival of Patients With Stage I NSCLC

Zhejiang Cancer Hospital0 sites237 target enrollmentJanuary 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non-small Cell Lung Cancer
Sponsor
Zhejiang Cancer Hospital
Enrollment
237
Primary Endpoint
Correlation between driver gene mutation and survival prognosis in regional lymph nodes of early stage NSCLC
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Analysis of driver gene variation in early stage non-small cell lung cancer

Detailed Description

Fluorescence quantitative polymerase chain reaction (PCR) was used to detect the variation of driver gene in regional lymph nodes of early stage non-small cell lung cancer (NSCLC), and to analyze the relationship between the variation and disease recurrence and survival prognosis. evaluate the effect of the variation of driving gene in lymph nodes of early stage NSCLC on prognosis, identify the high-risk factors that promote the recurrence and metastasis of early stage tumor. so as to improve the diagnosis and treatment path of lung cancer, provide important pathological basis for the clinical diagnosis and treatment of early stage non-small cell lung cancer, enable patients to receive more accurate treatment, and improve their survival prognosis.

Registry
clinicaltrials.gov
Start Date
January 2009
End Date
June 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

zjszlyyad@126.com

Director of pathology

Zhejiang Cancer Hospital

Eligibility Criteria

Inclusion Criteria

  • Female or male, 18 years of age or older
  • Histologically or cytologically proven diagnosis of early stage NSCLC
  • The lesion was completely resected by radical surgery
  • Able to get tumor tissue sample
  • Complete information of clinicopathological , survival, recurrence and metastasis can be obtained through follow-up

Exclusion Criteria

  • Combine with other tumor type
  • The investigator judges the situation that may affect the clinical search process and results

Outcomes

Primary Outcomes

Correlation between driver gene mutation and survival prognosis in regional lymph nodes of early stage NSCLC

Time Frame: 2019

Observe the correlation between driver gene mutation and survival prognosis in regional lymph nodes of early stage NSCLC

Correlation of Clinicopathological characteristics and driver gene mutation in regional lymph nodes of early stage NSCLC

Time Frame: 2019

Analyze the correlation between driver gene mutation and clinicopathological features in regional lymph nodes of early stage NSCLC

Driver gene mutation frequency of early stage NSCLC

Time Frame: 2019

Observe the driver gene mutation frequency in regional lymph nodes of early stage non-small cell lung cancer

Similar Trials